The US Food and Drug Administration (FDA) has granted approval to a tablet formulation of BeOne Medicines’ targeted cancer ...

BioNTech has announced that it will be expanding its messenger RNA (mRNA) capabilities by acquiring CureVac for approximately ...

It’s not about just engaging with patients, it is about co-creating with patients, making them integral at every stage ...

GSK’s Blenrep (belantamab mafodotin) has been recommended by the National Institute for Health and Care Excellence (NICE) as ...

The US Food and Drug Administration (FDA) has approved Nuvation Bio’s Ibtrozi (taletrectinib) to treat adults with a rare and ...

These are the first clinical study results for the drug in a large population of patients with darker skin tones ...

That is why global cooperation is so crucial to rare disease research. National, international and community partnerships and ...

Alongside the data in PsA, UCB will present at EULAR new results demonstrating that Bimzelx delivered sustained clinical ...

Today, by contrast, the marketers I study complain of being swamped by data and confused by information overload. And when I ...

Galderma has shared positive two-year data for its monoclonal antibody Nemluvio (nemolizumab) in moderate-to-severe atopic ...

NewAmsterdam Pharma has shared promising Alzheimer’s disease (AD) biomarker data from a late-stage study of its ...

Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) has been approved by the European Commission (EC) to treat adults with ...